Cargando…
Establishment and Characterization of Patient-Derived Xenografts (PDXs) of Different Histology from Malignant Pleural Mesothelioma Patients
SIMPLE SUMMARY: Malignant pleural mesothelioma (MPM) is a rare tumor with unfavorable prognosis for which new therapeutic interventions are urgently needed. The aim of our study was to develop a preclinical model representative of the different histotypes found in human tumors that can be used as mo...
Autores principales: | Affatato, Roberta, Mendogni, Paolo, Del Gobbo, Alessandro, Ferrero, Stefano, Ricci, Francesca, Broggini, Massimo, Rosso, Lorenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7766019/ https://www.ncbi.nlm.nih.gov/pubmed/33419364 http://dx.doi.org/10.3390/cancers12123846 |
Ejemplares similares
-
Isolation and characterization of two newly established thymoma PDXs from two relapses of the same patient: a new tool to investigate thymic malignancies
por: Mendogni, Paolo, et al.
Publicado: (2022) -
Studying cancer immunotherapy using patient-derived xenografts (PDXs) in humanized mice
por: Choi, Yunsik, et al.
Publicado: (2018) -
Assessment of patient-derived tumour xenografts (PDXs) as a discovery tool for cancer epigenomics
por: Guilhamon, Paul, et al.
Publicado: (2014) -
Management of Pleural Effusion Secondary to Malignant Mesothelioma
por: Musso, Valeria, et al.
Publicado: (2021) -
Genomic data analysis workflows for tumors from patient-derived xenografts (PDXs): challenges and guidelines
por: Woo, Xing Yi, et al.
Publicado: (2019)